Hong Kong makes belated bid to build biotech business

As Hong Kong belatedly wakes up to the benefits of biotechnology, Singapore streaks ahead.

More than a year after Singapore announced it would invest $1 billion to cultivate start-up biotechnology companies and make life sciences one of the main pillars of its economy, Hong Kong is finally taking action to catch up.

The government's Innovation and Technology Commission has put together a team headed by Sir Colin Dollery, senior consultant to SmithKline Beecham, to study Hong Kong's resources and make recommendations on how it can best take advantage of the genetic...

To continue reading, please login or register for free

Click for more on: hong | kong | makes | belated | bid | build | biotech | business

Print Edition

FinanceAsia Print Edition